SCHEMBL846403

SCHEMBL846403

O=C(Nc1cnc2ccccc2c1)c1ccc(N2CCN(c3ccccc3)CC2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.72
NPC1 O15118 7/20 0.66
RAB9A P51151 6/20 0.66
KDM4E B2RXH2 4/20 0.66
MITF O75030 1/20 0.66
XBP1 P17861 1/20 0.66
PAX8 Q06710 1/20 0.66
KLF5 Q13887 1/20 0.66
ALDH1A1 P00352 3/20 0.64
TRPV1 Q8NER1 11/20 0.63
SMN1; SMN2 Q16637 5/20 0.58
HSD17B10 Q99714 3/20 0.57
USP2 O75604 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
THRB P10828 1/20 0.57
HPGD P15428 1/20 0.57
MAPK1 P28482 1/20 0.57
LMNA P02545 1/20 0.57
PKM P14618 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845964 0.93 KDR (0.68) KDRNPC1RAB9AKDM4EMITF
SCHEMBL848116 0.92 NPC1 (0.65) KDRNPC1RAB9AKDM4EMITF
SCHEMBL846030 0.92 KDR (0.67) KDRNPC1RAB9AKDM4EMITF
SCHEMBL846074 0.92 KDR (0.67) KDRNPC1RAB9AKDM4EMITF
SCHEMBL846300 0.92 KDR (0.67) KDRNPC1RAB9AKDM4EMITF
SCHEMBL846379 0.92 KDR (0.67) KDRNPC1RAB9AKDM4EMITF
SCHEMBL845220 0.91 NPC1 (0.66) KDRNPC1RAB9AKDM4EMITF
SCHEMBL846520 0.90 KDR (0.64) KDRNPC1RAB9AKDM4EMITF
SCHEMBL846927 0.90 KDR (0.64) KDRNPC1RAB9AKDM4EMITF
SCHEMBL846408 0.90 KDR (0.64) KDRNPC1RAB9AKDM4EMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP disclosed
EP-2308848-A1 Quinoline-derived amide modulators of vanilloid VR1 receptor Janssen Pharmaceutica NV (BE) 2011-04-13 EP disclosed